Surface Oncology, Inc. - Common Stock (NQ:SURF)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 7, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Surface Oncology, Inc. - Common Stock

< Previous 1 2 3 Next >

Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences

August 31, 2023

Urges Stockholders to Vote Promptly to Ensure Their Shares are Represented at the September 7th Special Meeting

From Surface Oncology, Inc.

Via GlobeNewswire

SURFACE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF

August 07, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023

August 02, 2023

From Surface Oncology, Inc.

Via GlobeNewswire

Health Care Company Coherus BioSciences Announces Merger With Surface Oncology ↗

June 16, 2023

Via Benzinga

Recap: Surface Oncology Q1 Earnings ↗

May 04, 2023

Via Benzinga

Downgrade Aside, Cathie Wood Buys $1.2M Worth Of SoFi Shares ↗

July 27, 2023

Via Benzinga

Cathie Wood's Ark Pours $3.3M More Into This Chipmaker Amid AI Frenzy: Here Are Other Major Monday Trades ↗

July 11, 2023

Via Benzinga

Cathie Wood's Ark Outshines S&P 500, Nasdaq In H1: Here Are The Major Trades It Made ↗

June 28, 2023

Via Benzinga

Cathie Wood Sells $7M Tesla Stock Friday Amid Pullback, Bets Big On This Crypto-Linked Stock ↗

June 24, 2023

Via Benzinga

SURFACE ONCOLOGY INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF

June 21, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Synergy Of Coherus And Surface Oncology: Analyst Forecasts $50M Savings And 2024 Profitability ↗

June 20, 2023

Truist Securities analyst Robyn Karnauskas reiterated a Buy rating on the shares of Coherus BioSciences, Inc.

Via Benzinga

Nasdaq Down 80 Points; US Consumer Sentiment Surges To 4-Month High In June ↗

June 16, 2023

U.S. stocks traded lower toward the end of trading, with Nasdaq Compsoite dropping around 80 points on Friday. The Dow traded down 0.24% to 34,324.18 while the NASDAQ fell 0.59% to 13,701.06. The S&P...

Via Benzinga

Crude Oil Rises; Adobe Posts Upbeat Results ↗

June 16, 2023

U.S. stocks traded slightly higher midway through trading, with Dow Jones gaining around 20 points on Friday. The Dow traded up 0.06% to 34,428.13 while the NASDAQ rose 0.05% to 13,789.23. The S&P 500,...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023 ↗

June 20, 2023

Via Benzinga

Coherus BioSciences, MicroVision, Millicom And Other Big Stocks Moving Lower On Friday ↗

June 16, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording losses in today’s session. Coherus BioSciences, Inc. (NASDAQ: CHRS) tumbled 16.8%...

Via Benzinga

Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 16, 2023

Gainers Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781.

Via Benzinga

SURF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surface Oncology, Inc. Is Fair to Shareholders

June 16, 2023

From Halper Sadeh LLC

Via Business Wire

US Stocks Mixed; Dow Gains 50 Points ↗

June 16, 2023

U.S. stocks traded mixed this morning, with Dow Jones gaining around 50 points on Friday. Following the market opening Friday, the Dow traded up 0.16% to 34,464.01 while the NASDAQ fell 0.14% to...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 16, 2023

Via Benzinga

Coherus BioSciences Acquires Small Immuno-Oncology Player Surface Oncology For $40M ↗

June 16, 2023

Coherus BioSciences Inc (NASDAQ: CHRS) has agreed to acquire Surface Oncology Inc (NASDAQ: SURF), a clinical-stage immuno-oncology (I-O) company developing next-generation immunotherapies that

Via Benzinga

Coherus to Acquire Surface Oncology

June 16, 2023

From Surface Oncology, Inc.

Via GlobeNewswire

Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023

May 04, 2023

From Surface Oncology, Inc.

Via GlobeNewswire

Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023

April 18, 2023

– New in vivo data show SRF114 promotes a pro-inflammatory tumor microenvironment resulting in robust antitumor activity in mouse models –

From Surface Oncology, Inc.

Via GlobeNewswire

Surface Oncology to Present New Preclinical SRF114 Data at the American Association for Cancer Research (AACR) Annual Meeting 2023

March 16, 2023

From Surface Oncology, Inc.

Via GlobeNewswire

Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2022

March 09, 2023

From Surface Oncology, Inc.

Via GlobeNewswire

Surface Oncology to Participate in the Cowen 43rd Annual Health Care Conference

February 28, 2023

From Surface Oncology, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 09, 2023

Via Benzinga

Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference

February 02, 2023

From Surface Oncology, Inc.

Via GlobeNewswire

The 3 Best Biotech Stocks Under $1 to Buy for January ↗

January 26, 2023

Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich.

Via InvestorPlace

Vaccinex Announces First Patient Dosed with Anti-CCR8 Antibody Licensed to Surface Oncology

January 09, 2023

Surface Oncology initiates clinical trial with antibody discovered using Vaccinex’s ActivMAb® Antibody Discovery Platform

From Vaccinex, Inc.

Via GlobeNewswire

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.